Stomachs: Does the size matter? aspects of intestinal satiety, gastric satiety, hunger and gluttony

Clinics

Volumn 67, Issue 4, 2012, Pages 301-303

  Santoro, Sergio ^a  

^a Department of Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1;

ANIMAL; DIGESTION; EDITORIAL; HISTOLOGY; HUMAN; HUNGER; HYPERPHAGIA; INTESTINE ABSORPTION; MEAL; ORGAN SIZE; PATHOPHYSIOLOGY; PHYSIOLOGY; SATIETY; STOMACH; STOMACH EMPTYING;

ANIMALS; DIGESTION; GASTRIC EMPTYING; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HUNGER; HYPERPHAGIA; INTESTINAL ABSORPTION; MEALS; ORGAN SIZE; SATIATION; STOMACH;

EID: 84860132484     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(04)01     Document Type: Editorial

References (21)

1. Jenkins DJ, Wolever TM, Taylor RH, Ghafari H, Jenkins AL, Barker H, et al. Rate of digestion of foods and postprandial glycaemia in normal and diabetic subjects. Br Med J. 1980;281(6232):14-7, http://dx.doi.org/10.1136/bmj.281.6232.14.
2. Siegel EG, Creutzfeldt W. Stimulation of insulin release in isolated rat islets by GIP in physiological concentrations and its relation to islet cyclic AMP content. Diabetologia. 1985;28(11):857-61, http://dx.doi.org/10.1007/BF00291078.
3. Ross SA, Dupre J. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects. Diabetes 1978;27(3):327-33.
4. Meier JJ, Gallwitz B, Siepmann N, Holst JJ, Deacon CF, Schmidt WE, et al. Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia. Diabetologia 2003;46(6):798-801.
5. Bojanowska E. Physiology and pathophysiology of glucagon-like peptide-1 (GLP-1): The role of GLP-1 in the pathogenesis of diabetes mellitus, obesity, and stress. Med Sci Monit. 2005;11(8):RA271-8.
6. Ballantyne GH. Peptide YY(1-36) and Peptide YY(3-36): Part I. Distribution, Release and Actions. Obes Surg. 2006;16:651-8, http://dx.doi.org/10.1381/096089206776944959.
7. Cohen MA, Ellis SM, Le Roux CW, Batterham RL, Park A, Patterson M, et al. Oxyntomodulin Suppresses Appetite and Reduces Food Intake in Humans. J Clin Endocrinol Metab. 2003;88(10):4696-701, http://dx.doi.org/10.1210/jc.2003-030421.
8. Nauck MA, Niedereichholz U, Ettler R, Holst JJ, Orskov C, Ritzel R, et al. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol. 1997;273(5 Pt 1): E981-8.
9. Ranganath LR, Beety JM, Morgan LM, Wright JW, Howland R, Marks V. Attenuated GLP-1 secretion in obesity: cause or consequence? Gut. 1996;38(6):916-9, http://dx.doi.org/10.1136/gut.38.6.916.
10. Lugari R, Dei Cas A, Ugolotti D, Finardi L, Barilli AL, Ognibene C, et al. Evidence for early impairment of glucagon-like peptide 1-induced insulin secretion in human type 2 (non insulin-dependent) diabetes. Horm Metab Res. 2002;34(3):150-4.
11. Muccioli G, Tschop M, Papotti M, Deghenghi R, Heiman M, Ghigo E, et al. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 2002;440(2-3):235-54.
12. Schirra J, Wank U, Arnold R, Goke B, Katschinski M. Effects of glucagon-like peptide-1(7-36)amide on motility and sensation of the proximal stomach in humans. Gut. 2002;50(3):341-8, http://dx.doi.org/10.1136/gut.50.3.341.
13. Holst JJ. Postprandial Insulin Secretion After Gastric Bypass Surgery: The Role of Glucagon-Like Peptide 1. Diabetes 2011;60(9):2203-5.
14. Byrne TK. Complications of obesity surgery. Surg Clin North Am. 2001;81(5):1181-93, http://dx.doi.org/10.1016/S0039-6109(05)70190-0.
15. Santoro S. Adaptive and Neuroendocrine procedures: A new pathway in Bariatric and Metabolic Surgery. Obes Surg 2008;18(10):1343-45.
16. Milleo FQ, Campos AC, Santoro S, Lacombe A, Santo MA, Vicari MR, et al. Metabolic effects of an entero-omentectomy in mildly obese type 2 Diabetes Mellitus patients after three years. Clinics 2011;66(7):1227-33.
17. Santoro S, Castro LC, Velhote MCP, et al. Sleeve Gastrectomy with Transit Bipartition. A Potent Intervention for Metabolic Syndrome and Obesity. Ann Surg, in press.
18. Santoro S. Is the Metabolic Syndrome a Disease of the Foregut? Yes, Excessive Foregut. Ann Surg. 2008;247(6):1074-5.
19. de Paula AL, Macedo AL, Prudente AS, Queiroz L, Schraibman V, Pinus J. Laparoscopic sleeve gastrectomy with ileal interposition ("neuroendocrine brake")-pilot study of a new operation. Surg Obes Relat Dis. 2006;2(4):464-7, http://dx.doi.org/10.1016/j.soard.2006.03.005.
20. Santoro S, Malzoni CE, Velhote MC, Milleo FQ, Santo MA, Klajner S, et al. Digestive Adaptation with Intestinal Reserve: A neuroendocrine-based procedure for morbid obesity. Obes Surg. 2006;16(10):1371-9, http://dx.doi.org/10.1381/096089206778663841.
21. Santoro S. Is sleeve gastrectomy a restrictive or an adaptive procedure? Reflections on the concepts of restriction and adaptation. Ann Surg. 2010;252(5):892-3.